CD27⁺ microparticle interactions and immunoregulation of CD4⁺ T lymphocytes

Area of Science:

• Immunology
• Cell Biology
• Transfusion Medicine

Background:

• Platelet transfusions, used for aplasia and hematological malignancies, exert immunomodulatory effects.
• Platelet concentrates (PCs) contain various immunomodulatory components, including microparticles (MPs) and soluble CD27 (sCD27).
• CD27 expression loss marks terminal T-lymphocyte (TL) differentiation; CD27+ MPs in PCs may affect TL activation.

Purpose of the Study:

• To phenotype CD27-expressing MPs in PCs using microscale flow cytometry.
• To investigate the interaction between CD27+ MPs and CD4+ TLs.
• To determine the origin of CD27 on TLs after MP co-culture.

Main Methods:

• Phenotyping of CD27-expressing MPs in PCs via microscale flow cytometry.
• Co-culture of MPs with peripheral blood mononuclear cells (PBMCs).
• Use of fluorochromes to distinguish MP-derived vs. cellular CD27 on CD4+ TLs.

Main Results:

• CD27-expressing MPs bind to TLs through the CD70 molecule, also present on the MPs.
• Sorted CD27+ MPs maintained CD27 expression on TLs, resulting in lower activation levels compared to other MP types.
• The interaction involves CD70-mediated targeting of MPs to TLs.

Conclusions:

• CD27-expressing MPs and their CD70-mediated interactions present novel immunotherapy strategies.
• MPs could be utilized to maintain specific cell phenotypes or target immune cells.
• Reducing CD27+ MPs in transfused platelets may enhance anti-CD27 monoclonal immunotherapy efficacy.